Adipokine Dysregulation and Insulin Resistance with Atherosclerotic Vascular Disease: Metabolic Syndrome or Independent Sequelae?

Prospective Relation of Circulating Adipokines to Incident Metabolic Syndrome: The Framingham Heart Study

(2017) Justin P. Zachariah et al.   Journal of the American Heart Association

Leptin concentration and risk of coronary heart disease and stroke: A systematic review and meta-analysis

(2017) Han Yang et al.   PLoS One

MicroRNA-155 Deficiency Leads to Decreased Atherosclerosis, Increased White Adipose Tissue Obesity, and Non-alcoholic Fatty Liver Disease

(2016) Anthony Virtue et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment

(2016) Meric Erikci Ertunc et al.   JOURNAL OF LIPID RESEARCH

Adiponectin improves NF-κB-mediated inflammation and abates atherosclerosis progression in apolipoprotein E-deficient mice

(2016) Xuemei Wang et al.   Lipids in Health and Disease

Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders

(2016) A. Janus et al.   MEDIATORS OF INFLAMMATION

Adiponectin signaling and function in insulin target tissues

(2016) Hong Ruan et al.   Journal of Molecular Cell Biology

Association of Cholesterol Efflux Capacity With Clinical Features of Metabolic Syndrome: Relevance to Atherosclerosis

(2016) Julie Gall et al.   Journal of the American Heart Association

Plasminogen Activator Inhibitor‐1 and Diagnosis of the Metabolic Syndrome in a West African Population

(2016) Nuri Kodaman et al.   Journal of the American Heart Association

Insulin and Metabolic Stress Stimulate Multisite Serine/Threonine Phosphorylation of Insulin Receptor Substrate 1 and Inhibit Tyrosine Phosphorylation

(2014) Nancy J. Hançer et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Effect of advanced glycation end product intake on inflammation and aging: a systematic review

(2014) Katrien Van Puyvelde et al.   NUTRITION REVIEWS

Human circadian system causes a morning peak in prothrombotic plasminogen activator inhibitor-1 (PAI-1) independent of the sleep/wake cycle

(2013) F. A. J. L. Scheer et al.   BLOOD

Mechanisms of Lipotoxicity in the Cardiovascular System

(2012) Adam R. Wende et al.   CURRENT HYPERTENSION REPORTS

The Value of the Metabolic Syndrome Concept in Elderly Adults: Is It Worth Less Than the Sum of Its Parts?

(2012) Katherine Samaras et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Attributable mortality burden of metabolic syndrome: comparison with its individual components

(2011) Chi-Pang Wen et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

A systematic evaluation of the insulin resistance syndrome as an independent risk factor for cardiovascular disease mortality and derivation of a clinical index

(2011) Ian F. Godsland et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects

(2010) Manoj Mathew et al.   Cardiovascular Diabetology

Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-κB pathway in rat aorta

(2010) Hua Li et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Role of adipose tissue renin–angiotensin system in metabolic and inflammatory diseases associated with obesity

(2010) Laurent Yvan-Charvet et al.   KIDNEY INTERNATIONAL

Oxidized Low-Density Lipoprotein Inhibits Nitric Oxide-Mediated Coronary Arteriolar Dilation by Up-regulating Endothelial Arginase I

(2010) WEI WANG et al.   MICROCIRCULATION

Apelin is necessary for the maintenance of insulin sensitivity

(2009) Patrick Yue et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Metabolic Syndrome as a Risk Factor for Cardiovascular Disease, Mortality, and Progression of Diabetic Nephropathy in Type 1 Diabetes

(2009) L. M. Thorn et al.   DIABETES CARE

Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies

(2009) S. Del Prato   DIABETIC MEDICINE

Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome

(2009) E. Maury et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites

(2009) F. K. Swirski et al.   SCIENCE

Is hypertension an immunologic disease?

(2009) David G. Harrison et al.   Current Cardiology Reports

Endothelial Dysfunction in Impaired Fasting Glycemia, Impaired Glucose Tolerance, and Type 2 Diabetes Mellitus

(2008) Ying Su et al.   AMERICAN JOURNAL OF CARDIOLOGY

Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke

(2008) Cornelia Weikert et al.   CIRCULATION

Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity

(2008) J Hung et al.   INTERNATIONAL JOURNAL OF OBESITY

Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis

(2008) Hyung J. Chun et al.   JOURNAL OF CLINICAL INVESTIGATION

Critical Role of Bone Marrow Angiotensin II Type 1 Receptor in the Pathogenesis of Atherosclerosis in Apolipoprotein E–Deficient Mice

(2007) Daiju Fukuda et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY